Cirauqui C, Benito-Villalvilla C, Sanchez-Ramon S, Sirvent S, Diez-Rivero CM, Conejero L, et al. Human dendritic cells activated with MV130 induce Th1, Th17 and IL-10 responses via RIPK2 and MyD88 signalling pathways. European journal of immunology. 2018;48(1):180-93.
Molero-Abraham M, Sanchez-Trincado JL, Gomez-Perosanz M, Torres-Gomez A, Subiza JL, Lafuente EM, et al. Human Oral Epithelial Cells Impair Bacteria-Mediated Maturation of Dendritic Cells and Render T Cells Unresponsive to Stimulation. Frontiers in immunology. 2019;10:1434.
Vazquez A, Fernandez-Sevilla LM, Jimenez E, Perez-Cabrera D, Yanez R, Subiza JL, et al. Involvement of Mesenchymal Stem Cells in Oral Mucosal Bacterial Immunotherapy. Frontiers in immunology. 2020;11:567391.
Del Fresno C, Garcia-Arriaza J, Martinez-Cano S, Heras-Murillo I, Jarit-Cabanillas A, Amores-Iniesta J, et al. The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity. Frontiers in immunology. 2021;12:748103.
Bodas-Pinedo A, Lafuente EM, Pelaez-Prestel H, Ras Carmona Á, Subiza JL, Reche PA. Combining different bacteria in vaccine formulations enhances the chance for antiviral cross-reactive immunity: a detailed in silico analysis for influenza A virus. Frontiers in immunology. 2023;14:1235053.
Jiménez E, Vázquez A, González S, Sacedón R, Fernández-Sevilla LM, Varas A, et al. Mucosal Bacterial Immunotherapy Attenuates the Development of Experimental Colitis by Reducing Inflammation Through the Regulation of Myeloid Cells. International Journal of Molecular Sciences. 2024;25(24):13629.
Sevilla-Ortega C, Angelina A, Martín-Cruz L, Pérez-Diego M, Maldonado A, Lavín B, et al. A mucosal vaccine prevents eosinophilic allergic airway inflammation by modulating immune responses to allergens in a murine model of airway disease. Nat Commun. 2025;16(1):7129.
Alecsandru D, Valor L, Sanchez-Ramon S, Gil J, Carbone J, Navarro J, et al. Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: immunomodulatory effect on antigen-specific memory CD4+ T cells and impact on clinical outcome. Clinical and experimental immunology. 2011;164(1):100-7.
Garcia Gonzalez LA, Arrutia F. Mucosal bacterial immunotherapy with MV130 highly reduces the need of tonsillectomy in adults with recurrent tonsillitis. Human vaccines & immunotherapeutics. 2019.
Guevara-Hoyer K, Saz-Leal P, Diez-Rivero CM, Ochoa-Grullon J, Fernandez-Arquero M, Perez de Diego R, et al. Trained Immunity Based-Vaccines as a Prophylactic Strategy in Common Variable Immunodeficiency. A Proof of Concept Study. Biomedicines. 2020;8(7).
Carbone J, di Natale M, Salcedo M, Romero M, Laporta R, Carreño M, et al. Mucosal Bacterial Immunotherapy in solid organ recipients with recurrent respiratory tract infections: Case Report. Transplantation Case Report. 2020.
Ochoa-Grullon J, Benavente Cuesta C, Gonzalez Fernandez A, Cordero Torres G, Perez Lopez C, Pena Cortijo A, et al. Trained Immunity-Based Vaccine in B Cell Hematological Malignancies With Recurrent Infections: A New Therapeutic Approach. Frontiers in immunology. 2021;11:611566.
Nieto A, Mazon A, Nieto M, Calderon R, Calaforra S, Selva B, et al. Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical Trial. American journal of respiratory and critical care medicine. 2021;204(4):462-72.
Pérez-Sancristóbal I, de la Fuente E, Álvarez-Hernández MP, Guevara-Hoyer K, Morado C, Martínez-Prada C, et al. Long-Term Benefit of Perlingual Polybacterial Vaccines in Patients with Systemic Autoimmune Diseases and Active Immunosuppression. Biomedicines. 2023;11(4):1168.
Montalban-Hernandez K, Cogollo-Garcia A, Giron de Velasco-Sada P, Caballero R, Casanovas M, Subiza JL, et al. MV130 in the Prevention of Recurrent Respiratory Tract Infections: A Retrospective Real-World Study in Children and Adults. Vaccines (Basel). 2024;12(2).
Ndaferankhande J, Conejero Hall L, Dula D, Chirwa A, Nsoma E, Toto N, et al. The influence of MV130 immunotherapy on Nasal Colonisation in a Controlled Human Infection Model of Pneumococcal Carriage in Malawi. Wellcome Open Research. 2025;10;479.
Kotecha SJ, Lowe J, Gillespie D, Perez-Alijas M, Aboklaish AF, Mahachi TL, et al. Randomised, double-blind, parallel group, placebo-controlled, trial of Bactek for the prevention of lower respiratory tract infections in preterm infants in the UK: BALLOON study – study protocol. BMJ Open. 2026;16(3):e107929.
Sanchez-Ramon S, Conejero L, Netea MG, Sancho D, Palomares O, Subiza JL. Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations. Frontiers in immunology. 2018;9:2936.
de Boer GM, Zolkiewicz J, Strzelec KP, Ruszczynski M, Hendriks RW, Braunstahl GJ, et al. Bacterial lysate therapy for the prevention of wheezing episodes and asthma exacerbations: a systematic review and meta-analysis. Eur Respir Rev. 2020;29(158).
Nieto A, Nieto M, Conejero L, Subiza JL. Do bacterial vaccines/adjuvants prevent wheezing episodes in children? Current opinion in allergy and clinical immunology. 2022;22(6):7.
Minute L, Montalban-Hernandez K, Bravo-Robles L, Conejero L, Iborra S, Del Fresno C. Trained immunity-based mucosal immunotherapies for the prevention of respiratory infections. Trends in immunology. 2025;46(4):270-83.
